Cover Image
市場調查報告書

藥物遞輸的先進機制

Advanced Mechanisms in Drug Delivery

出版商 Technical Insights (Frost & Sullivan) 商品編碼 341672
出版日期 內容資訊 英文 74 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
藥物遞輸的先進機制 Advanced Mechanisms in Drug Delivery
出版日期: 2015年09月30日 內容資訊: 英文 74 Pages
簡介

本報告提供傳統、新興電信業者或技術分類的藥物遞輸機制的相關調查、各技術的評估、藥物遞輸產業上主要企業的相關利益者分析、技術藍圖,及主要專利等相關資料彙整。

第1章 摘要整理

第2章 藥物遞輸的檢討

第3章 技術評估

  • 技術藍圖
  • 高分子奈米微胞
  • Niosomes
  • 亞磷酸
  • 澱粉基載體
  • 微脂體
  • 微乳化
  • 磁奈米粒子 (MNP) / 中孔二氧化矽系統 (MSP)
  • 磁奈米粒子 (MNP)
  • 生物分解可能顯微組織貼片技術
  • 環糊精
  • 功能性奈米微胞 / 生物模仿微囊泡 / 奈米體
  • 超分子結構
  • 微膠囊化相變材料
  • 液晶體奈米粒子 / 膽固醇液晶 / 液晶樹狀聚合物
  • 液晶體奈米粒子

第4章 創新的擴散、需求評估

  • 技術形勢
  • 需求面方面分析

第5章 主要打入市場企業的相關利益者分析

  • 相關利益者分析
  • SWOT分析

第6章 主要打入市場企業的資金評估

第7章 機會的評估

  • 新興技術發展藍圖
  • 聯盟的評估
  • 技術經營管理策略

第8章 IP形勢

第9章 主要的契約、專利

第10章 關於Frost&Sullivan

目錄
Product Code: D6A0-01-00-00-00

Impact and assessment of modern mechanisms in drug delivery systems

Drug delivery refers to the efficient transport of an active pharmaceutical compound to provide a therapeutic effect that is required by the human body. Drug delivery systems are extremely crucial for patients who require regular doses of medication through the prescribed route of administration. The research study deals with drug delivery mechanisms that are categorized as existing and emerging carriers or technologies that deliver the therapeutic at the target site. Drug delivery industry has witnessed a sea change as majority of the conventional carriers such as polymeric micelles, dendrimers and niosomes are being slowly replaced by emerging approaches such as cyclodextrins, microemulsions, hydrogels, etc. due to their ability to improve drug solubility and bioavailability which help the drug cope with the hostile nature of the gastro-intestinal tract. The research study covers the stakeholder analysis of the key players in the drug delivery industry, particularly the drug delivery technology developers and pharmaceutical manufacturers and also assesses the technology adoption with respect to these mechanisms. Finally, opportunity evaluation has been conducted to understand the scope of future mechanisms in drug delivery with the help of a technology roadmap, partnerships model that assess the partnerships based on technology licensing, product development and distribution and the IP landscape that evaluate the level of interest of existing and emerging technologies amongst key stakeholders.

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

  • 1. Research Process Methodology
  • 2. Research Methodology (continued)
  • 3. Key Findings

2. SNEAK PREVIEW INTO DRUG DELIVERY

Sneak Preview into Drug Delivery

  • 1. Overview

3. TECHNOLOGY ASSESSMENT

Technology Assessment

  • 1. Technology Roadmap
  • 2. Polymeric Micelles
  • 3. Polymeric Micelles
  • 4. Niosomes
  • 5. Phosphorous Acids
  • 6. Starch-Based Carrier
  • 7. Starch-Based Carrier
  • 8. Liposomes
  • 9. Liposomes
  • 10. Microemulsions
  • 11. Microemulsions
  • 12. Magnetic Nanoparticles (MNPs)/ Mesoporous silica systems (MSPs)
  • 13. Magnetic Nanoparticles (MNPs)
  • 14. Biodegradable Microstructure Patch Technology
  • 15. Biodegradable Microstructure Patch Technology
  • 16. Cyclodextrins
  • 17. Cyclodextrins
  • 18. Functional Micelles/Biomimetic Microvesicles/Nanosomes
  • 19. Functional Micelles/Biomimetic Microvesicles/Nanosomes
  • 20. Functional Micelles/Biomimetic Microvesicles/Nanosomes
  • 21. Supramolecular Architectures
  • 22. Supramolecular Architectures
  • 23. Microencapsulated Phase Change Materials
  • 24. Microencapsulated Phase Change Materials
  • 25. Fluid Crystal Nanoparticles/Cholesteric Liquid Crystal/Liquid Crystalline Dendrimers
  • 26. Fluid Crystal Nanoparticles

4. DIFFUSION OF INNOVATIONS AND NEEDS ASSESSMENT

Diffusion of Innovations and Needs Assessment

  • 1. Technology Landscape
  • 2. Demand side Analysis

5. STAKEHOLDER ANALYSIS OF KEY PARTICIPANTS

Stakeholder Analysis of Key Participants

  • 1. Stakeholder Analysis
  • 2. Stakeholder Analysis (continued)
  • 3. Stakeholder analysis (continued)
  • 4. SWOT analysis of Key Participants

6. FUNDING ASSESSMENT OF KEY PARTICIPANTS

Funding Assessment of Key Participants

  • 1. Funding Assessment
  • 2. Funding Assessment (continued)

7. OPPORTUNITY EVALUATION

Opportunity Evaluation

  • 1. Emerging Technology Roadmap
  • 2. Emerging Technology Roadmap
  • 3. Assessment of Partnerships
  • 4. Assessment of Partnerships (continued)
  • 5. Assessment of Partnershipscontinued)
  • 6. Assessment of Partnerships (continued)
  • 7. Assessment of Partnerships (continued)
  • 8. Assessment of Partnerships (continued)
  • 9. Technology Management Strategies

8. IP LANDSCAPE

IP Landscape

  • 1. Patent scenario
  • 2. Patent scenario (..contd)

9. KEY CONTACTS AND PATENTS

Key Contacts and Patents

  • 1. Key contacts
  • 2. Global Patents
  • 3. Global Patents (continued)
  • 4. Legal Disclaimer

10. THE FROST & SULLIVAN STORY

The Frost & Sullivan Story

  • 1. The Frost & Sullivan Story
  • 2. Value Proposition: Future of Your Company & Career
  • 3. Global Perspective
  • 4. Industry Convergence
  • 5. 360° Research Perspective
  • 6. Implementation Excellence
  • 7. Our Blue Ocean Strategy
Back to Top